Patents by Inventor Detlef Dieckmann

Detlef Dieckmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10006901
    Abstract: The present invention provides suppressive and/or regulative human CD4+CD25+ T cells, a method for expanding same, and the use of the suppressive and/or regulative human CD4+CD25+ T cells and the expanded T cells as regulatory agent.
    Type: Grant
    Filed: June 22, 2012
    Date of Patent: June 26, 2018
    Assignee: ARGOS THERAPEUTICS, INC.
    Inventors: Gerold Schuler, Detlef Dieckmann
  • Patent number: 8603815
    Abstract: The invention provides CD4+CD25? T cells and Tr1-like regulatory T cells (i.e., contact-independent Type 1-like regulatory T cells), processes for their production and their use for regulatory purposes.
    Type: Grant
    Filed: November 4, 2011
    Date of Patent: December 10, 2013
    Assignee: Argos Therapeutics, Inc.
    Inventors: Gerold Schuler, Detlef Dieckmann
  • Publication number: 20120328563
    Abstract: The present invention provides suppressive and/or regulative human CD4+CD25+ T cells, a method for expanding same, and the use of the suppressive and/or regulative human CD4+CD25+ T cells and the expanded T cells as regulatory agent.
    Type: Application
    Filed: June 22, 2012
    Publication date: December 27, 2012
    Applicant: ARGOS THERAPEUTICS, INC.
    Inventors: GEROLD SCHULER, DETLEF DIECKMANN
  • Patent number: 8222033
    Abstract: The invention provides CD4+CD25? T cells and Tr1-like regulatory T cells (i.e., contact-independent Type 1-like regulatory T cells), processes for their production and their use for regulatory purposes.
    Type: Grant
    Filed: July 11, 2003
    Date of Patent: July 17, 2012
    Assignee: Argos Therapeutics, Inc.
    Inventors: Gerold Schuler, Detlef Dieckmann
  • Publication number: 20120114597
    Abstract: The invention provides CD4+CD25? T cells and Tr1-like regulatory T cells (i.e., contact-independent Type 1-like regulatory T cells), processes for their production and their use for regulatory purposes.
    Type: Application
    Filed: November 4, 2011
    Publication date: May 10, 2012
    Applicant: ARGOS THERAPEUTICS, INC.
    Inventors: Gerold SCHULER, Detlef DIECKMANN
  • Patent number: 8076134
    Abstract: The invention provides CD4+CD25? T cells and Tr1-like regulatory T cells (i.e., contact-independent Type 1-like regulatory T cells), processes for their production and their use for regulatory purposes.
    Type: Grant
    Filed: June 20, 2007
    Date of Patent: December 13, 2011
    Assignee: Argos Therapeutics, Inc.
    Inventors: Gerold Schuler, Detlef Dieckmann
  • Publication number: 20070258959
    Abstract: The invention provides CD4+CD25? T cells and Tr1-like regulatory T cells (i.e., contact-independent Type 1-like regulatory T cells), processes for their production and their use for regulatory purposes.
    Type: Application
    Filed: June 20, 2007
    Publication date: November 8, 2007
    Inventors: GEROLD SCHULER, DETLEF DIECKMANN
  • Publication number: 20050101012
    Abstract: The present invention provides suppressive and/or regulative human CD4+CD25+ T cells, a method for expanding same, and the use of the suppressive and/or regulative human CD4+CD25+ T cells and the expanded T cells as regulatory agent.
    Type: Application
    Filed: September 12, 2003
    Publication date: May 12, 2005
    Inventors: Gerold Schuler, Detlef Dieckmann
  • Publication number: 20040147021
    Abstract: The invention provides CD4+CD25− T cells and Tr1-like regulatory T cells (i.e., contact-independent Type 1-like regulatory T cells), processes for their production and their use for regulatory purposes.
    Type: Application
    Filed: July 11, 2003
    Publication date: July 29, 2004
    Inventors: Gerold Schuler, Detlef Dieckmann